Vasoactive intestinal peptide modification at position 22 allows discrimination between receptor subtypes

Author： Gourlet P.   Vandermeers-Piret M.-C.   Rathe J.   De Neef P.   Cnudde J.   Robberecht P.   Waelbroeck M.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.348, Iss.1, 1998-05, pp. : 95-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lack of evidence for cross-competition between vasoactive intestinal peptide and somatostatin at their respective receptors

By Hannon J.P.   Langenegger D.   Waser B.   Hoyer D.   Reubi J.-C.  

European Journal of Pharmacology, Vol. 426, Iss. 3, 2001-08 ,pp. : 165-173

Elsevier

Access to resources Recommend Favorite

A study of the chemical and biological stability of vasoactive intestinal peptide

By Cui Xu   Cao Deying   Qu Changhai   Zhang Xiaoyan   Zheng Aiping  

Drug Development and Industrial Pharmacy, Vol. 39, Iss. 12, 2013-12 ,pp. : 1907-1910

Informa Healthcare

Access to resources Recommend Favorite

Vasoactive intestinal peptide prevents experimental arthritis

By  

Inpharma, Vol. 1, Iss. 1293, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Vasoactive Intestinal Peptide in Neurodevelopmental Disorders:Therapeutic Potential

By  

Current Pharmaceutical Design, Vol. 13, Iss. 11, 2007-01 ,pp. : 1079-1089

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutical Approaches of Vasoactive Intestinal Peptide as a Pleiotropic Immunomodulator

By  

Current Pharmaceutical Design, Vol. 13, Iss. 11, 2007-04 ,pp. : 1113-1139

Bentham Science Publishers

Access to resources Recommend Favorite